Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme 1 selected

Guidance programme

Showing 1 to 5 of 5

TitleReference numberPublishedLast updated
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusionTA283
Ranibizumab and pegaptanib for the treatment of age-related macular degenerationTA155
Ranibizumab for treating choroidal neovascularisation associated with pathological myopiaTA298
Ranibizumab for treating diabetic macular oedemaTA274
Ranibizumab for treating diabetic retinopathy (terminated appraisal)TA637

Results per page

  1. 10
  2. 25
  3. 50
  4. All